- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
GOL.2: 5 residues within 4Å:- Chain A: R.249, D.253, Q.257
- Chain B: R.314
- Ligands: NDP.9
3 PLIP interactions:2 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:R.249, A:D.253
- Water bridges: B:R.314
GOL.3: 6 residues within 4Å:- Chain A: S.6, G.7, G.8, E.36, L.37, D.38
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:S.6, A:G.8, A:E.36
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
NDP.4: 30 residues within 4Å:- Chain A: E.17, K.72, A.74, T.75, I.76, T.77, R.82, N.96, L.288, G.289, A.307, A.308, H.309, G.310, T.311, V.312, T.313, R.314, H.315, S.326, T.327, N.328, D.375
- Chain B: T.214, L.250, D.252, D.253, Q.257, K.260
- Ligands: AKG.1
28 PLIP interactions:24 interactions with chain A, 4 interactions with chain B- Hydrogen bonds: A:K.72, A:T.75, A:T.75, A:T.75, A:T.77, A:T.77, A:T.77, A:R.82, A:R.82, A:N.96, A:G.310, A:T.311, A:V.312, A:R.314, A:N.328, A:N.328, B:Q.257
- Water bridges: A:T.313, A:R.314, A:H.315, A:H.315, A:A.331, B:D.253, B:K.260
- Salt bridges: A:R.314, A:H.315, B:K.260
- pi-Stacking: A:H.309
NDP.9: 30 residues within 4Å:- Chain A: T.214, L.250, D.252, D.253, Q.257, K.260
- Chain B: E.17, K.72, A.74, T.75, I.76, T.77, R.82, N.96, R.100, L.288, G.289, A.308, H.309, G.310, T.311, V.312, T.313, R.314, H.315, T.327, N.328, D.375
- Ligands: GOL.2, AKG.8
23 PLIP interactions:3 interactions with chain A, 20 interactions with chain B- Hydrogen bonds: A:D.253, A:Q.257, B:K.72, B:T.75, B:T.75, B:T.77, B:R.82, B:R.82, B:N.96, B:G.310, B:T.311, B:V.312, B:N.328, B:N.328
- Salt bridges: A:K.260, B:R.314, B:H.315
- Water bridges: B:T.313, B:R.314, B:H.315, B:H.315, B:A.331
- pi-Stacking: B:H.309
- 2 x CA: CALCIUM ION(Non-covalent)
CA.5: 5 residues within 4Å:- Chain A: R.109, D.275, D.279
- Chain B: D.252
- Ligands: AKG.1
5 PLIP interactions:2 interactions with chain A, 1 interactions with chain B, 2 Ligand-Water interactions- Metal complexes: A:D.275, A:D.275, B:D.252, H2O.3, H2O.4
CA.7: 5 residues within 4Å:- Chain A: D.252
- Chain B: R.109, D.275, D.279
- Ligands: AKG.8
5 PLIP interactions:2 interactions with chain B, 1 interactions with chain A, 2 Ligand-Water interactions- Metal complexes: B:D.275, B:D.279, A:D.252, H2O.6, H2O.7
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reinbold, R. et al., Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 2.10 Å
- Oligo State
- homo-dimer
- Ligands
- 2 x AKG: 2-OXOGLUTARIC ACID(Non-covalent)
- 2 x GOL: GLYCEROL(Non-functional Binders)
- 2 x NDP: NADPH DIHYDRO-NICOTINAMIDE-ADENINE-DINUCLEOTIDE PHOSPHATE(Non-covalent)
- 2 x CA: CALCIUM ION(Non-covalent)
- 2 x CL: CHLORIDE ION(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Reinbold, R. et al., Resistance to the isocitrate dehydrogenase 1 mutant inhibitor ivosidenib can be overcome by alternative dimer-interface binding inhibitors. Nat Commun (2022)
- Release Date
- 2022-07-13
- Peptides
- Isocitrate dehydrogenase [NADP] cytoplasmic: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B